Central Nervous System Disease in Langerhans Cell Histiocytosis

Journal of Pediatrics

Volumn 156, Issue 6, 2010, Pages

  Grois, Nicole ^a   Fahrner, Bernhard ^a   Arceci, Robert J ^b   Henter, Jan Inge ^g   McClain, Kenneth ^c   Lassmann, Hans ^d   Nanduri, Vasanta ^e   Prosch, Helmut ^f   Prayer, Daniela ^f  

^a St Anna Children's Cancer Research Institute   (Austria)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c TEXAS CHILDREN S CANCER CENTER   (United States)

^d Medical University of Vienna   (Austria)

^e WATFORD GENERAL HOSPITAL   (United Kingdom)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

^g KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIINFLAMMATORY AGENT; CLADRIBINE; CYTARABINE; ETOPOSIDE; IMATINIB; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; NEUROPROTECTIVE AGENT; PREDNISONE; RETINOIC ACID; VINBLASTINE; VINCRISTINE;

ARTICLE; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CRANIOPHARYNGIOMA; DEGENERATIVE DISEASE; DIABETES INSIPIDUS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; GERM CELL TUMOR; HISTIOCYTOSIS X; HUMAN; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; SARCOIDOSIS;

EID: 77952421771     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2010.03.001     Document Type: Article

References (65)

1. Schmitz L., and Favara B.E. Nosology and pathology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 12 (1998) 221-246
2. Arico M., and Egeler R.M. Clinical aspects of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 12 (1998) 247-258
3. Grois N., Prosch H., Waldhauser F., Minkov M., Strasser G., Steiner M., et al. Pineal gland abnormalities in Langerhans cell histiocytosis. Pediatr Blood Cancer 43 (2004) 261-266
4. Saatci I., Baskan O., Haliloglu M., and Aydingoz U. Cerebellar and basal ganglion involvement in Langerhans cell histiocytosis. Neuroradiology 41 (1999) 443-446
5. Polizzi A., Coghill S., McShane M.A., and Squier W. Acute ataxia complicating Langherans cell histiocytosis. Arch Dis Child 86 (2002) 130-131
6. Grois N.G., Favara B.E., Mostbeck G.H., and Prayer D. Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am 12 (1998) 287-305
7. Histiocyte Society, Group. LCS. LCH CNS 2003 Registry and Diagnostic Guidelines for Central Nervous System Disease in Langerhans Cell Histiocytosis. LCH CNS 2003 Study Protocol (2003)
8. Tien R., Kucharczyk J., and Kucharczyk W. MR imaging of the brain in patients with diabetes insipidus. AJNR Am J Neuroradiol 12 (1991) 533-542
9. Warmuth-Metz M., Genkow A.K., Müller H., and Solymosi L. Differential diagnosis of suprasellar tumors in children. Klin Paediatr 216 (2004) 323-330
10. Barthez M.A., Araujo E., and Donadieu J. Langerhans cell histiocytosis and the central nervous system in childhood: evolution and prognostic factors. Results of a collaborative study. J Child Neurol 15 (2000) 150-156
11. Prayer D., Grois N., Prosch H., Gadner H., and Barkovich A.J. MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis. AJNR Am J Neuroradiol 25 (2004) 880-891
12. Grois N., Barkovich A.J., Rosenau W., and Ablin A.R. Central nervous system disease associated with Langerhans' cell histiocytosis. Am J Pediatr Hematol Oncol 15 (1993) 245-254
13. Martin-Duverneuil N., Idbaih A., Hoang-Xuan K., Donadieu J., Genereau T., Guillevin R., et al. MRI features of neurodegenerative Langerhans cell histiocytosis. Eur Radiol 16 (2006) 2074-2082
14. Prosch H., Grois N., Wnorowski M., Steiner M., and Prayer D. Long-term MR imaging course of neurodegenerative Langerhans cell histiocytosis. Am J Neuroradiol 28 (2007) 1022-1028
15. Buchler T., Cervinek L., Belohlavek O., Kantorova I., Mechl M., Nebesky T., et al. Langerhans cell histiocytosis with central nervous system involvement: follow-up by FDG-PET during treatment with cladribine. Pediatr Blood Cancer 44 (2005) 286-288
16. Steiner M., Prayer D., Asenbaum S., Prosch H., Minkov M., Unger E., et al. Modern imaging methods for the assessment of Langerhans' cell histiocytosis-associated neurodegenerative syndrome: case report. J Child Neurol 20 (2005) 253-257
17. Calming U., Bemstrand C., Mosskin M., Elander S.S., Ingvar M., and Henter J.I. Brain 18-FDG PET scan in central nervous system Langerhans cell histiocytosis. J Pediatr 141 (2002) 435-440
18. Ribeiro M.J., Idbaih A., Thomas C., Remy P., Martin-Duverneuil N., Samson Y., et al. 18F-FDG PET in neurodegenerative Langerhans cell histiocytosis: results and potential interest for an early diagnosis of the disease. J Neurol 255 (2008) 575-580
19. Phillips M., Allen C., Gerson P., and McClain K. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Pediatr Blood Cancer 52 (2009) 97-101
20. Kepes J.J. Histiocytosis X. In: Vinken P.J., and Brujn G.W. (Eds). Handbook of neurology (1979), Elsevier Publishing Company, New York 93-117
21. Grois N., Prayer D., Prosch H., and Lassmann H. Neuropathology of CNS disease in Langerhans cell histiocytosis. Brain 128 Pt 4 (2005) 829-838
22. Nanduri V.R., Bareille P., Pritchard J., and Stanhope R. Growth and endocrine disorders in multisystem Langerhans' cell histiocytosis. Clin Endocrinol (Oxf) 53 (2000) 509-515
23. Haupt R., Nanduri V., Calevo M.G., Bernstrand C., Braier J.L., Broadbent V., et al. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group. Pediatr Blood Cancer 42 (2004) 438-444
24. Grois N., Potschger U., Prosch H., Minkov M., Arico M., Braier J., et al. Risk factors for diabetes insipidus in langerhans cell histiocytosis. Pediatr Blood Cancer 46 (2006) 228-233
25. Donadieu J., Rolon M.A., Thomas C., Brugieres L., Plantaz D., Francois Emile J., et al. Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a population-based study. J Pediatr 144 (2004) 344-350
26. Bernstrand C., Sandstedt B., Ahstrom L., and Henter J.I. Long-term follow-up of Langerhans cell histiocytosis: 39 years' experience at a single centre. Acta Paediatr 94 (2005) 1073-1084
27. Grois N., Flucher-Wolfram B., Heitger A., Mostbeck G.H., Hofmann J., and Gadner H. Diabetes insipidus in Langerhans cell histiocytosis: results from the DAL-HX 83 study. Med Pediatr Oncol 24 (1995) 248-256
28. A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. The French Langerhans' Cell Histiocytosis Study Group. Arch Dis Child 75 (1996) 17-24
29. Maghnie M., Cosi G., Genovese E., Manca-Bitti M.L., Cohen A., Zecca S., et al. Central diabetes insipidus in children and young adults. N Engl J Med 343 (2000) 998-1007
30. Czernichow P., Garel C., and Leger J. Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus. Horm Res 53 Suppl. 3 (2000) 61-64
31. Prosch H., Grois N., Bokkerink J., Prayer D., Leuschner I., Minkov M., et al. Central diabetes insipidus: is it Langerhans cell histiocytosis of the pituitary stalk? A diagnostic pitfall. Pediatr Blood Cancer 46 (2006) 363-366
32. Wnorowski M., Prosch H., Prayer D., Janssen G., Gadner H., and Grois N. Pattern and course of neurodegeneration in Langerhans cell histiocytosis. J Pediatr 153 (2008) 127-132
33. Mittheisz E., Seidl R., Prayer D., Waldenmair M., Neophytou B., Potschger U., et al. Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis. Pediatr Blood Cancer 48 (2007) 50-56
34. Komp D.M. Long-term sequelae of histiocytosis X. Am J Pediatr Hematol Oncol 3 (1981) 163-168
35. Whitsett S.F., Kneppers K., Coppes M.J., and Egeler R.M. Neuropsychologic deficits in children with Langerhans cell histiocytosis. Med Pediatr Oncol 33 (1999) 486-492
36. Shuper A., Stark B., Yaniv Y., Zaizov R., Carel C., Sadeh M., et al. Cerebellar involvement in Langerhans' cell histiocytosis: a progressive neuropsychiatric disease. J Child Neurol 15 (2000) 824-826
37. Nanduri V.R., Lillywhite L., Chapman C., Parry L., Pritchard J., and Vargha-Khadem F. Cognitive outcome of long-term survivors of multisystem Langerhans cell histiocytosis: a single-institution, cross-sectional study. J Clin Oncol 21 (2003) 2961-2967
38. Vrijmoet-Wiersma C.M., Kooloos V.M., Koopman H.M., Kolk A.M., van der Laan I., Grootenhuis M.A., et al. Health-related quality of life, cognitive functioning and behaviour problems in children with Langerhans cell histiocytosis. Pediatr Blood Cancer 52 (2009) 116-122
39. Gavhed D., Akefeldt S.O., Osterlundh G., Laurencikas E., Hjorth L., Blennow K., et al. Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis. Pediatr Blood Cancer 53 (2009) 1264-1270
40. D'Ambrosio N., Soohoo S., Warshall C., Johnson A., and Karimi S. Craniofacial and intracranial manifestations of Langerhans cell histiocytosis: report of findings in 100 patients. AJR Am J Roentgenol 191 (2008) 589-597
41. Dunger D.B., Broadbent V., Yeoman E., Seckl J.R., Lightman S.L., Grant D.B., et al. The frequency and natural history of diabetes insipidus in children with Langerhans cell histiocytosis. N Engl J Med 321 (1989) 1157-1162
42. The French Langerhans Cell Histiocytosis Group. A multicentric retrospective survey of Langerhans cell histiocytosis: 348 cases observed between 1983 and 1993. Arch Dis Child 75 (1996) 17-24
43. Gadner H, Grois N, Minkov M, Pötschger U, Thiem E, Histiocyte Society. Treatment protocol of the third international study for Langerhans Cell Histiocytosis. 2001.
44. Harris G.J., and Woo K.I. Is unifocal Langerhans-cell histiocytosis of the orbit a "CNS-risk" lesion?. Pediatr Blood Cancer 43 (2004) 298-299 author reply 300-1
45. Nicole Grois M., and Helmut Gadner M. Re: is unifocal Langerhans cell histiocytosis of the orbit a ''CNS-risk'' lesion?. Pediatr Blood Cancer 43 (2004) 300-301
46. Gadner H., Heitger A., Grois N., Gatterer-Menz I., and Ladisch S. Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group. Med Pediatr Oncol 23 (1994) 72-80
47. Grois N., Prayer D., Prosch H., Minkov M., Potschger U., and Gadner H. Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis. Pediatr Blood Cancer 43 (2004) 59-65
48. Laurencikas E., Stalemark H., Fadeel B., Prayer D., Grois N., and Henter J. Incidence of abnormal magnetic resonance imaging findings of the central nervous system in children with Langerhans cell histiocytosis. Abstract Pediatr Blood Cancer 46 (2006) 394
49. Dhall G., Finlay J.L., Dunkel I.J., Ettinger L.J., Kellie S.J., Allen J.C., et al. Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine. Pediatr Blood Cancer 50 (2008) 72-79
50. Rosenzweig K.E., Arceci R.J., and Tarbell N.J. Diabetes insipidus secondary to Langerhans' cell histiocytosis: is radiation therapy indicated?. Med Pediatr Oncol 29 (1997) 36-40
51. Broadbent V., and Pritchard J. Diabetes insipidus associated with Langerhans cell histiocytosis: is it reversible?. Med Pediatr Oncol 28 (1997) 289-293
52. Minehan K.J., Chen M.G., Zimmerman D., Su J.Q., Colby T.V., and Shaw E.G. Radiation therapy for diabetes insipidus caused by Langerhans cell histiocytosis. Int J Radiat Oncol Biol Phys 23 (1992) 519-524
53. Minehan K.J., Chen M.G., Zimmermann D., Su J.Q., Colby T.V., and Shaw E.G. Radiation therapy for diabetes insipidus caused by Langerhans' cell histiocytosis. Int J Radiat Oncol Biol Phys 23 (1992) 519-524
54. Greenberger J.S., Cassady J.R., Jaffe N., Vawter G., and Crocker A.C. Radiation therapy in patients with histiocytosis: management of diabetes insipidus and bone lesions. Int J Radiat Oncol Biol Phys 5 (1979) 1749-1755
55. Ottaviano F., and Finlay J.L. Diabetes insipidus and Langerhans cell histiocytosis: a case report of reversibility with 2-chlorodeoxyadenosine. J Pediatr Hematol Oncol 25 (2003) 575-577
56. Grois N., Favara B., Mostbeck G., and Prayer D. Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am 12 (1998) 287-305
57. Watts J., and Files B. Langerhans cell histiocytosis: central nervous system involvement treated successfully with 2-chlorodeoxyadenosine. Pediatr Hematol Oncol 18 (2001) 199-204
58. Pardanani A., Phyliky R.L., Li C.Y., and Tefferi A. 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis. Mayo Clin Proc 78 (2003) 301-306
59. Montella L., Insabato L., and Palmieri G. Imatinib mesylate for cerebral Langerhans'-cell histiocytosis. N Engl J Med 35 (2004) 1034-1035
60. Idbaih A., Donadieu J., Barthez M.A., Geissmann F., Bertrand Y., Hermine O., et al. Retinoic acid therapy in "degenerative-like" neuro-Langerhans cell histiocytosis: a prospective pilot study. Pediatr Blood Cancer 43 (2004) 55-58
61. Imashuku S., Shioda Y., Kobayashi R., Hosoi G., Fujino H., Seto S., et al. Neurodegenerative central nervous system disease as late sequelae of Langerhans cell histiocytosis. Report from the Japan LCH Study Group. Haematologica 93 (2008) 615-618
62. Allen C.E., Flores R., Rauch R., Dauser R., Murray J.C., Puccetti D., et al. Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside. Pediatr Blood Cancer 11 (2009) 416-423
63. Bjartmar C., Kidd G., Mork S., Rudick R., and Trapp B.D. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 48 (2000) 893-901
64. Lloyd. CNS compensation to dopamine neuron loss in Parkinson's disease. PMID: 930746. Adv Exp Med Biol 90 (1977) 255-266
65. Bradley W.G. Recent views on amyotrophic lateral sclerosis with emphasis on electrophysiological studies. Muscle Nerve 10 (1987) 490-502